Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K /Akt Pathway
Microbial Biotechnology · 2025-01 · 18 (1)
DOI: 10.1111/1751-7915.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 18.01.2025. Verfasst von Ruonan Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Chemical and Drug Induced Liver Injury, Disulfiram. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: "YiQi''funding project.
Abstract (Originalsprache)
Acetaminophen induced acute liver injury (ALI) has a high incidence and is a serious medical problem, but there is a lack of effective treatment. The enterohepatic axis is one of the targets of recent attention due to its important role in liver diseases. Disulfiram (DSF) is a multitarget drug that has been proven to play a role in a variety of liver diseases and can affect intestinal flora, but whether it can alleviate ALI is not clear. We utilised bacterial 16S rRNA gene profiling, antimicrobial treatments, and faecal microbiota transplantation tests to explore whether DSF therapy for ALI is dependent on gut microbiota. Our findings indicate that DSF primarily restores intestinal microbiome balance by modulating the abundance of Akkermansia muciniphila ( A. muciniphila ), leading to significant alleviation of ALI symptoms in a gut microbiota dependent manner. We also found that A. muciniphila can promote the activation of PI3K/Akt pathway, correct the Bcl‐2/Bax ratio, and further inhibit hepatocyte apoptosis. In conclusion, DSF ameliorates ALI by modulating the intestinal microbiome and activating the PI3K/AKT pathway through A. muciniphila .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology, Nanjing Medical University, Nanjing, China.
- Huadong Medical Institute of Biotechniques, Nanjing, China.
- The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Ruonan Zhang
Förderung
- "YiQi''funding project
Zitieren
APA
Zhang, R., Sun, X., Lu, H., Zhang, X., Zhang, M., Ji, X., Yu, X., Tang, C., Wu, Z., Mao, Y., Zhu, J., Ji, M., & Yang, Z. (2025). Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K /Akt Pathway. Microbial Biotechnology, 18(1). https://doi.org/10.1111/1751-7915.70083
Vancouver
Zhang R, Sun X, Lu H, Zhang X, Zhang M, Ji X, et al. Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K /Akt Pathway. Microbial Biotechnology. 2025;18(1). doi:10.1111/1751-7915.70083
BibTeX
@article{Zhang2025,
author = {Zhang, Ruonan and Sun, Xuewei and Lu, Han and Zhang, Xinrui and Zhang, Mingyan and Ji, Xuewen and Yu, Xinyi and Tang, Chengliang and Wu, Zihan and Mao, Yinghua and Zhu, Jin and Ji, Minjun and Yang, Zhan},
title = {Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K /Akt Pathway},
journal = {Microbial Biotechnology},
year = {2025},
volume = {18},
number = {1},
doi = {10.1111/1751-7915.70083}
}
EUVIMED